HK1037877A1 - Paroxetine methanesulfonate acetonitrile solvate 1:1 - Google Patents

Paroxetine methanesulfonate acetonitrile solvate 1:1

Info

Publication number
HK1037877A1
HK1037877A1 HK01107165A HK01107165A HK1037877A1 HK 1037877 A1 HK1037877 A1 HK 1037877A1 HK 01107165 A HK01107165 A HK 01107165A HK 01107165 A HK01107165 A HK 01107165A HK 1037877 A1 HK1037877 A1 HK 1037877A1
Authority
HK
Hong Kong
Prior art keywords
acetonitrile solvate
paroxetine methanesulfonate
methanesulfonate acetonitrile
paroxetine
solvate
Prior art date
Application number
HK01107165A
Other languages
English (en)
Inventor
Victor Witold Jacewicz
Michael William John Urquhart
Andrew Simon Craig
David Alan Jones
Deirdre O'keeffe
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27269380&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1037877(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9814316.7A external-priority patent/GB9814316D0/en
Priority claimed from GBGB9821732.6A external-priority patent/GB9821732D0/en
Priority claimed from GBGB9902935.7A external-priority patent/GB9902935D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HK1037877A1 publication Critical patent/HK1037877A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK01107165A 1998-07-02 2001-10-11 Paroxetine methanesulfonate acetonitrile solvate 1:1 HK1037877A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds
GBGB9821732.6A GB9821732D0 (en) 1998-10-06 1998-10-06 Novel compound
GBGB9902935.7A GB9902935D0 (en) 1999-02-10 1999-02-10 Novel compound
PCT/GB1999/001253 WO2000001694A1 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate

Publications (1)

Publication Number Publication Date
HK1037877A1 true HK1037877A1 (en) 2002-02-22

Family

ID=27269380

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01107165A HK1037877A1 (en) 1998-07-02 2001-10-11 Paroxetine methanesulfonate acetonitrile solvate 1:1

Country Status (35)

Country Link
US (4) US6063927A (nl)
EP (5) EP1020463A1 (nl)
JP (1) JP2002519422A (nl)
KR (1) KR20010053336A (nl)
CN (1) CN1127502C (nl)
AR (2) AR011759A1 (nl)
AT (4) ATE251155T1 (nl)
AU (4) AU713131B3 (nl)
BE (3) BE1011664A6 (nl)
BR (1) BR9911682A (nl)
CA (1) CA2269999A1 (nl)
CH (1) CH689805A8 (nl)
DE (5) DE19918588A1 (nl)
DK (7) DK1089996T3 (nl)
ES (4) ES2149044T3 (nl)
FI (2) FI4209U1 (nl)
FR (2) FR2780728B1 (nl)
GB (5) GB2352395B (nl)
GR (3) GR990100140A (nl)
HK (1) HK1037877A1 (nl)
HU (1) HUP0102334A3 (nl)
IE (5) IES20000894A2 (nl)
IL (1) IL140628A (nl)
IT (1) IT1312540B1 (nl)
LU (1) LU90388B1 (nl)
NL (4) NL1011875C2 (nl)
NO (1) NO319030B1 (nl)
NZ (1) NZ509180A (nl)
PL (1) PL345214A1 (nl)
PT (4) PT102291B (nl)
SE (1) SE9901462A0 (nl)
SI (3) SI0970955T1 (nl)
SK (1) SK20262000A3 (nl)
TR (1) TR200100054T2 (nl)
WO (1) WO2000001694A1 (nl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998401A (en) * 1995-02-28 1999-12-07 Eli Lilly And Company Naphthyl compounds, intermediates, compositions, and methods
EP0968746B1 (en) * 1997-02-27 2003-10-15 Ajinomoto Co., Inc. Crystallization apparatus and crystallization method
US5874447A (en) * 1997-06-10 1999-02-23 Synthon B. V. 4-Phenylpiperidine compounds for treating depression
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
US20040028582A1 (en) * 1999-03-10 2004-02-12 Smithkline Beecham Corporation Crystallization process for producing fine crystal products
USPP12225P2 (en) 1999-06-01 2001-11-27 Florfis Ag Geranium plant named ‘Fislamda’
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina
AU5078700A (en) * 1999-06-22 2001-01-09 Smithkline Beecham Plc Novel composition
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
US6306435B1 (en) 2000-06-26 2001-10-23 Yung Shin Pharmaceutical Industrial Co. Ltd. Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
NZ523902A (en) * 2000-08-28 2004-05-28 Synthon Bv Paroxetine compositions and processes for making the same
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
NL1017421C2 (nl) * 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
CA2456233A1 (en) * 2001-08-02 2003-03-13 Spurcourt Limited Paroxetine isethionate salt, process of preparation and use in the treatment of depression
EP1490090A4 (en) 2002-02-22 2006-09-20 New River Pharmaceuticals Inc SYSTEMS FOR DELIVERING ACTIVE AGENTS AND METHODS FOR PROTECTING AND DELIVERING ACTIVE AGENTS
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
WO2006018318A1 (en) * 2004-08-18 2006-02-23 Synthon B.V. Liquid paroxetine compositions
US20060039975A1 (en) * 2004-08-20 2006-02-23 Zalman Vilkov Paroxetine formulations
KR100672184B1 (ko) 2004-09-21 2007-01-19 주식회사종근당 파록세틴의 콜린산 또는 콜린산 유도체 염
CA2603832C (en) * 2005-04-07 2011-11-22 Xy, Inc. Flow path conditioner system
CA2629514A1 (en) * 2005-11-14 2007-05-24 Auspex Pharmaceuticals, Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
EP1966192B1 (en) * 2005-12-01 2012-10-17 Pfizer Products Inc. Pyrimidine derivatives for the treatment of abnormal cell growth
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
CN101627031A (zh) * 2007-03-09 2010-01-13 诺瓦提斯公司 3-(1h-吲哚-3-基)-4-[2-(4-甲基-哌嗪-1-基)-喹唑啉-4-基]-吡咯-2,5-二酮的盐
US20100249166A1 (en) * 2007-09-19 2010-09-30 Xy, Inc. Differential evaporation potentiated disinfectant system
US8119688B2 (en) * 2007-09-19 2012-02-21 Xy, Llc Differential evaporation potentiated disinfectant system
FR2926552B1 (fr) * 2008-01-23 2010-03-26 Biocodex Procede de preparation de particules de stiripentol ayant une granulometrie definie
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法
CN104523645A (zh) * 2014-11-20 2015-04-22 美吉斯制药（厦门）有限公司 甲磺酸帕罗西汀片芯及其包衣片的制备方法
US11111373B2 (en) 2018-12-05 2021-09-07 Chi Mei Corporation Polymethacrylate composition and optical device made therefrom, and display apparatus

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE99678C (nl) *
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US4585777A (en) * 1984-02-07 1986-04-29 A/S Ferrosan (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0190496A3 (en) * 1984-12-13 1987-05-27 Beecham Group Plc Piperidine derivatives having a gastro-intestinal activity
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
EP0223334B1 (en) * 1985-08-10 1991-07-10 Beecham Group Plc Process for the preparation of aryl-piperidine carbinols
EP0223430B1 (en) * 1985-10-21 1991-02-27 Honda Giken Kogyo Kabushiki Kaisha Method for controlling the solenoid current of a solenoid valve which controls the amount of suction of air in an internal combustion engine
DE3688827T2 (de) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
JPS63141967A (ja) * 1986-11-21 1988-06-14 エイ・エッチ・ロビンス・カンパニー・インコーポレーテッド 抗アレルギー薬として有用な１−アリールオキシー４−［（４−アリール）−１−ピペラジニル］−２−ブタノール
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
DK716088D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Reduktion af piperidin-dion-derivater samt intermediat
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
CA2096853A1 (en) * 1990-11-24 1992-05-25 Anthony Michael Johnson Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5258517A (en) * 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine
JP2773587B2 (ja) * 1992-11-30 1998-07-09 東レ株式会社 Ｏ，ｏ´−ジアシル酒石酸無水物の製造法
US5276042A (en) * 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
US5546683A (en) * 1993-09-29 1996-08-20 Clark; George J. Bucket attachment device with remote controlled retractable pins
IT1274241B (it) * 1993-12-03 1997-07-15 Smithkline Beecham Farma Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5668134A (en) * 1994-01-28 1997-09-16 G. D. Searle & Co. Method for preventing or reducing photosensitivity and/or phototoxicity reactions to medications
GB9402029D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Plc Novel formulation
CA2143070C (en) * 1994-02-22 2001-12-18 Pankaj Modi Oral controlled release liquid suspension pharmaceutical formulation
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
SK283608B6 (sk) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie
GB2297550C2 (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
MX9707585A (es) * 1995-04-03 1997-12-31 Abbott Lab Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada.
NZ307479A (en) * 1995-05-17 1999-08-30 Novo Nordisk As A process for preparing 4-(4-halo substituted phenyl)-3-(3,4-methylenedioxy phenoxy methyl)piperidine derivatives
JP2813768B2 (ja) * 1995-05-24 1998-10-22 農林水産省家畜衛生試験場長 口蹄疫診断用ペプチドおよび当該ペプチドを含有する口蹄疫診断用抗原
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
WO1997016448A1 (en) * 1995-10-31 1997-05-09 Merck & Co., Inc. Process for preparing substituted azetidinones
IT1276160B1 (it) * 1995-11-22 1997-10-27 Recordati Chem Pharm Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee
GB9526645D0 (en) * 1995-12-28 1996-02-28 Chiroscience Ltd Stereoselective synthesis
ES2117557B1 (es) * 1996-02-29 1999-07-01 Ferrer Int Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina.
JP3446468B2 (ja) * 1996-04-15 2003-09-16 旭硝子株式会社 ピペリジンカルビノール類の製造方法
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
JP3882224B2 (ja) * 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
DE69739561D1 (de) * 1996-06-13 2009-10-15 Sumitomo Chemical Co Piperidin Derivative als Zwischenprodukte zur Herstellung von Paroxetine und Verfahren zu ihrer Herstellung
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
US5672609A (en) * 1996-07-18 1997-09-30 Eli Lilly And Company Pyridine compounds, intermediates compositions and methods of use
CA2187128A1 (en) * 1996-10-04 1997-06-26 K. S. Keshava Murthy New and useful polymorph of anhydrous paroxetine hydrochloride
US5874447A (en) * 1997-06-10 1999-02-23 Synthon B. V. 4-Phenylpiperidine compounds for treating depression
SK11812000A3 (sk) * 1998-02-06 2001-08-06 Smithkline Beecham Plc Soli paroxetínu, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie
KR20010041947A (ko) * 1998-03-16 2001-05-25 피터 기딩스 결정 형태의 파록세틴
ID26879A (id) * 1998-04-09 2001-02-15 Smithkline Beecham Plc Paroksetin maleat
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat

Also Published As

Publication number Publication date
TR200100054T2 (tr) 2001-06-21
IES990343A2 (en) 2000-01-02
IL140628A (en) 2004-06-20
ITMI990866A1 (it) 2000-10-23
NL1011875C2 (nl) 2000-03-24
CN1127502C (zh) 2003-11-12
PT1020464E (pt) 2001-10-30
EP1020464B1 (en) 2001-07-04
PT102291A (pt) 2000-05-31
US6063927A (en) 2000-05-16
GR990100140A (el) 2000-03-31
WO2000001694A1 (en) 2000-01-13
SI0970955T1 (en) 2001-02-28
EP1020463A1 (en) 2000-07-19
IES81166B2 (en) 2000-05-31
ATE251155T1 (de) 2003-10-15
SI1089996T1 (en) 2004-04-30
DE60000003T2 (de) 2002-03-21
AT3185U3 (de) 2000-01-25
AU713131B3 (en) 1999-11-25
DK199900554A (da) 2000-01-03
NO991944D0 (no) 1999-04-23
IT1312540B1 (it) 2002-04-22
ES2158778B1 (es) 2002-03-16
AU732211C (en) 2004-05-06
CA2269999A1 (en) 2000-01-02
EP1020464A1 (en) 2000-07-19
JP2002519422A (ja) 2002-07-02
BE1011664A6 (fr) 1999-11-09
DK199900234U4 (da) 2000-12-22
SI1020464T1 (en) 2001-12-31
GB9909505D0 (en) 1999-06-23
DK1089996T3 (da) 2004-02-09
GR3034328T3 (en) 2000-12-29
GB2336364B (en) 2000-05-10
AU732211B2 (en) 2001-04-12
EP1089996A1 (en) 2001-04-11
DK1020464T3 (da) 2001-09-24
ES2157881T3 (es) 2001-09-01
AU3619199A (en) 2000-01-24
PT970955E (pt) 2000-11-30
GB0119695D0 (en) 2001-10-03
GB0216752D0 (en) 2002-08-28
CH689805A8 (fr) 2000-02-29
AU2392899A (en) 2000-01-20
DK199900176U3 (da) 1999-08-13
IES20000894A2 (en) 2001-05-30
DE29907248U1 (de) 1999-09-09
BE1012403A5 (fr) 2000-10-03
EP0970955A1 (en) 2000-01-12
NL1012271A1 (nl) 1999-07-12
PT1089996E (pt) 2004-02-27
AR011759A1 (es) 2000-09-13
GB2352395B (en) 2004-02-11
FI112077B (fi) 2003-10-31
GB2377637A (en) 2003-01-22
US20020035130A1 (en) 2002-03-21
ATE202777T1 (de) 2001-07-15
NO991944L (no) 2000-01-03
FIU990190U0 (fi) 1999-04-23
IES20000893A2 (en) 2001-05-30
GR1003350B (el) 2000-03-29
ES2149044T3 (es) 2000-10-16
US20020193406A1 (en) 2002-12-19
DE69911774D1 (de) 2003-11-06
NO319030B1 (no) 2005-06-06
DE69900007T2 (de) 2001-06-07
IE990344A1 (en) 2000-05-03
LU90388B1 (fr) 2001-01-29
SE9901462A0 (sv) 2000-01-03
DE69911774T2 (de) 2004-08-05
FI990922A0 (fi) 1999-04-23
SE9901462L (nl)
GB2367003A (en) 2002-03-27
FI4209U1 (fi) 1999-11-10
AT3185U2 (de) 1999-11-25
DK199900234U1 (da) 2000-12-22
DE60000003D1 (de) 2001-08-09
BE1012420A6 (fr) 2000-10-03
ES2158778A1 (es) 2001-09-01
FR2780728A1 (fr) 2000-01-07
GB2336364A (en) 1999-10-20
ES2209428T3 (es) 2004-06-16
SK20262000A3 (sk) 2001-07-10
GB2352395A (en) 2001-01-31
CH689805A5 (fr) 1999-11-30
DE69900007D1 (de) 2000-09-07
KR20010053336A (ko) 2001-06-25
IL140628A0 (en) 2002-02-10
IE20000633A1 (en) 2001-10-17
GB9920332D0 (en) 1999-11-03
NL1012272C1 (nl) 1999-07-12
DK200000390U1 (da) 2000-12-27
EP0970955B1 (en) 2000-08-02
NL1011875A1 (nl) 2000-01-07
PT102291B (pt) 2002-07-31
NL1012271C2 (nl) 1999-09-23
GB2339428A (en) 2000-01-26
HUP0102334A3 (en) 2003-12-29
ATE195121T1 (de) 2000-08-15
US20010023253A1 (en) 2001-09-20
GB0026487D0 (en) 2000-12-13
BR9911682A (pt) 2001-12-26
CN1315949A (zh) 2001-10-03
HUP0102334A2 (hu) 2002-05-29
DE19918588A1 (de) 2000-01-27
FR2780728B1 (fr) 2001-02-16
DK0970955T3 (da) 2000-10-09
GR3036208T3 (en) 2001-10-31
NL1011874C1 (nl) 1999-07-12
EP1288214A1 (en) 2003-03-05
SE9901462D0 (sv) 1999-04-23
NZ509180A (en) 2001-06-29
AR018197A1 (es) 2001-10-31
FR2802098A1 (fr) 2001-06-15
PL345214A1 (en) 2001-12-03
EP1089996B1 (en) 2003-10-01
FI990922A (fi) 2000-01-03
AU713877B3 (en) 1999-12-09

Similar Documents

Publication Publication Date Title
HK1037877A1 (en) Paroxetine methanesulfonate acetonitrile solvate 1:1
IL123129A (en) Www addressing
HUP0101042A3 (en) Multi-axis hinge arrangement
GB2331534B (en) Centralizer
PL347541A1 (en) 5ht1
IL137329A0 (en) Vla-4 antagonists
PL343378A1 (en) Paroxetine maleate
PL343095A1 (en) Paroxetine compositions
GB2334454B (en) Putter
TW404265U (en) Improved structure for body-heightening machine
TW366045U (en) Improved structure for hinge
TW392634U (en) Moveable car-lifting-machine structure
GB9803200D0 (en) Moveable steplift
TW356075U (en) Improved structure for calender
TW362559U (en) Improved structure for connecting rod
TW348553U (en) Structure improvement for golf head
PL341899A1 (en) Vla-4 antagonists
TW359974U (en) Improved structure for shoe-repairing machine
TW356183U (en) Improved structure for wind-shielding block
TW385666U (en) Improved structure for wardrobe
TW349379U (en) Structure for shoes-shining machine
TW424657U (en) Extractable tool structure
TW342721U (en) Vertical folding running-machine
PL335344A1 (en) Shaped plinth component for doors

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090423